| NAFLD | Non-alcoholic fatty liver disease |
| HCC | Hepatocellular carcinoma |
| HBV | Hepatitis B |
| HBC | Hepatitis C |
| AASLD | American Association of the Study of the Liver |
| BMI | Body mass index |
| BCLC | Barcelona Clinic Liver Cancer |
| mRECIST | Modified Response Evaluation Criteria in Solid Tumours |
| INR | International Normalised Ratio/Prothrombin time |
| AFP | Alpha-fetoprotein |
| ALT | Alanine aminotransferase |
| AST | Aspartate aminotransferase |
| GGT | Gamma-glutamyltransferase |
| ALP | Alkaline phosphatase |
| CI | Confidence interval |
| DEB-TACE | Drug-eluting bead transarterial chemoembolization |
| IL-6 | Interleukin-6 |
| TNF-α | Tumour necrosis factor alpha |
| IGF | Insulin-like growth factor |
| CP | Child–Pugh |
| SIRTEX | SIR-Spheres Yttrium-90 resin microspheres |
| RFA | Radiofrequency ablation |
| MWA | Microwave ablation |